ConductScience.org, home

Paper41908232

Irreversible electroporation for localized prostate cancer: risk-stratified oncologic outcomes and functional preservation.

Xia ZY and 6 others. Prostate Int, 2026. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Irreversible electroporation for localized prostate cancer: risk-stratified oncologic outcomes and functional preservation. Papers, record 41908232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41908232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Irreversible electroporation for localized prostate cancer: risk-stratified oncologic outcomes and functional preservation.
PubMed
Journal
Prostate Int
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-08-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xia ZYZhi-Yu
2Xiang JCJia-Cheng
3Yang YXYu-Xuan
4Xiao FFan
5Yang JJun
6Wang SGShao-Gang
7Xia QDQi-Dong

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127809908Cognitive biases associated with medical decisions: a systematic review.BMC Med Inform Decis Mak2016https://conductscience.org/library/papers/27809908PubMed
236910902Irreversible electroporation for prostate cancer using PSMA PET-CT.Prostate Int2023https://conductscience.org/library/papers/36910902PubMed
335125113Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients.BMC Med2022https://conductscience.org/library/papers/35125113PubMed
436509074NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.J Natl Compr Canc Netw2022https://conductscience.org/library/papers/36509074PubMed
530342843Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.Eur Urol2019https://conductscience.org/library/papers/30342843PubMed
637748776Artificial intelligence-assisted ultrasound-guided focused ultrasound therapy: a feasibility study.Int J Hyperthermia2023https://conductscience.org/library/papers/37748776PubMed
737544833A multi-institutional study of 1,111 men with 4K score, multiparametric magnetic resonance imaging, and prostate biopsy.Urol Oncol2023https://conductscience.org/library/papers/37544833PubMed
839589586Advances in irreversible electroporation for prostate cancer.Discov Oncol2024https://conductscience.org/library/papers/39589586PubMed
939668103Recent Patterns and Trends in Global Prostate Cancer Incidence and Mortality: An Update.Eur Urol2025https://conductscience.org/library/papers/39668103PubMed
1034162858Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells.Nat Commun2021https://conductscience.org/library/papers/34162858PubMed
1137409092Combination of multiparametric magnetic resonance imaging and transperineal template-guided mapping prostate biopsy to determine potential candidates for focal therapy.Prostate Int2023https://conductscience.org/library/papers/37409092PubMed
1227595377New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.Eur Urol2017https://conductscience.org/library/papers/27595377PubMed
1339505512Prostate cancer theragnostics biomarkers: An update.Investig Clin Urol2024https://conductscience.org/library/papers/39505512PubMed
1438614820EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.Eur Urol2024https://conductscience.org/library/papers/38614820PubMed
1524656178Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy.J Vasc Interv Radiol2014https://conductscience.org/library/papers/24656178PubMed
1640053175A preliminary follow-up study on irreversible electroporation therapy in older patients with prostate cancer.Discov Oncol2025https://conductscience.org/library/papers/40053175PubMed
1732208094High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy.Radiology2020https://conductscience.org/library/papers/32208094PubMed
1838572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1940221374Long-term Oncological Outcomes of Partial Gland Cryoablation of Localized Prostate Cancer with Median Follow-up of 7 Years: A Single-institution Experience.Eur Urol Focus2025https://conductscience.org/library/papers/40221374PubMed
2037858454Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer.Eur Urol2024https://conductscience.org/library/papers/37858454PubMed

See all 30 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
42382550Irreversible electroporation in focal therapy for prostate cancer: current status and future directions.Prostate Int2026https://conductscience.org/library/papers/42382550

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NPEPPS9520PubTator's text mininghttps://conductscience.org/library/genes/9520

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41908232

GET https://conductscience.org/api/papers/v1/41908232/references?page=2